Drug
durvalumab
Marketed as IMFINZI.
Generic name
durvalumab
Brand names
IMFINZI
First FDA approval
2017-05-01
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| BLA761069 | IMFINZI | 2017-05-01 | ASTRAZENECA UK LTD |
Manufacturers
ASTRAZENECA UK LTD
Frequently asked questions
When was durvalumab FDA approved?
Earliest FDA approval on record: 2017-05-01.
What brand names are sold as durvalumab?
IMFINZI.
Sources
Appeal a durvalumab denial
Upload your denial — DenialHelp drafts a physician-ready appeal letter in five minutes with the right clinical guideline and federal regulation cited. $39 first-level, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com